Lonza Group
Price
Price
Historical dividends and forecast
Lonza Group has so far distributed $4.431 in 2024. The next dividend will be paid on 15.05.2025
CHART BY
Frequently asked questions
What is Lonza Group's market capitalization?
What is Lonza Group's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for Lonza Group?
What are the analyst ratings and target price for Lonza Group's stock?
What is Lonza Group's revenue over the trailing twelve months?
What is the EBITDA for Lonza Group?
What is the free cash flow of Lonza Group?
What is the 5-year beta of Lonza Group's stock?
How many employees does Lonza Group have, and what sector and industry does it belong to?
What is the free float of Lonza Group's shares?
Financials
Market Cap
$42.47B5Y beta
1.23EPS (TTM)
$8.946Free Float
69.83MP/E ratio (TTM)
65.73Revenue (TTM)
$7.55BEBITDA (TTM)
$1.17BFree Cashflow (TTM)
-$377.62MPricing
Analyst Ratings
The price target is $655.78 and the stock is covered by 23 analysts.
Buy
20
Hold
2
Sell
1
Information
Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life science industries. The Company's offerings include custom development and manufacturing of drugs and drug delivery systems, as well as development of anti-microbial solutions for commercial applications. The Company divides its activities into two segments: Pharma&Biotech and Specialty Ingredients. The Pharma&Biotech comprises the Company's Biologics, Small-Molecule, and Consumables and Research Tools businesses. The segment includes mammalian, microbial, chemical, bioconjugates, cell and gene therapy technology platforms. The Specialty Ingredients segment focuses on anti-microbial applications within Consumer Health division, which covers hygiene, nutrition and personal care products, as well as preservatives, capsules and food supplements, among others, and Consumer & Resources Protection division, which includes coatings and composites, and agro ingredients.
17,834
Biotechnology & Drugs
Health Care
Identifier
ISIN
Primary Ticker